SLU Nuclear Medicine Technology Alum Earns Position at a World Leader in Nuclear Medicine
Saint Louis University (SLU) Nuclear Medicine Technology (NMT) alum and current SLU MBA student Antonio Brnjic recently earned a position at one of the premiere radiopharmaceutical developers and manufacturers in the world: Curium. Brnjic will work as a product monitoring specialist and will monitor safety, efficacy and quality of their North American products.
Brnjic was very impressed with large impact that Curium has on people around the world by creating radiopharmaceuticals used to diagnose and treat patients. He went on to discuss some of what excites him about this new position.
“I’m excited to really understand how Curium interacts with their customers and the steps they take to ensure their products are safe for patients. I’m also really excited to also get a glimpse into regulatory affairs later down the road,” Brnjic said. “This company has a lot of potential and it will only keep on growing. I’m excited for what the future holds at Curium.”
Brnjic went on to explain how the SLU NMT program laid a great foundation for his career and helped him earn this new position at Curium.
“The NMT program at SLU gave me a solid understanding of nuclear medicine and encouraged me to build upon it. In addition, the clinical rotations certainly helped me interact with patients and use various radiopharmaceuticals for imaging and diagnosing,” Brnjic said. “This knowledge gives me a foundation for Curium’s products and aides me in helping any problems that may arise.”
SLU NMT Program Director Crystal Botkin, Ph.D., MPH, CNMT, PET, FSNMMI-TS, was very proud of Brnjic for earning a position with one of the leaders in the field of nuclear medicine.
“It was truly a pleasure to work with Antonio throughout his educational journey at SLU. He was always motivated to do and learn more,” Dr. Botkin said. “I am honored to have had the opportunity to be a part of his educational pursuits and am excited to see where his journey takes him.”
Curium specializes in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, Curium’s products empower their customers with effective treatment and proven patient outcomes.
Saint Louis University is a Catholic, Jesuit institution that values academic excellence, life-changing research, compassionate health care, and a strong commitment to faith and service. Founded in 1818, the University fosters the intellectual and character development of nearly 13,000 students on two campuses in St. Louis and Madrid, Spain. Building on a legacy of more than 200 years, Saint Louis University continues to move forward with an unwavering commitment to a higher purpose, a greater good.